BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25312269)

  • 1. Common genetic variants in NEFL influence gene expression and neuroblastoma risk.
    Capasso M; Diskin S; Cimmino F; Acierno G; Totaro F; Petrosino G; Pezone L; Diamond M; McDaniel L; Hakonarson H; Iolascon A; Devoto M; Maris JM
    Cancer Res; 2014 Dec; 74(23):6913-24. PubMed ID: 25312269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility.
    Capasso M; Diskin SJ; Totaro F; Longo L; De Mariano M; Russo R; Cimmino F; Hakonarson H; Tonini GP; Devoto M; Maris JM; Iolascon A
    Carcinogenesis; 2013 Mar; 34(3):605-11. PubMed ID: 23222812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.
    Capasso M; McDaniel LD; Cimmino F; Cirino A; Formicola D; Russell MR; Raman P; Cole KA; Diskin SJ
    J Cell Mol Med; 2017 Dec; 21(12):3224-3230. PubMed ID: 28667701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between
    Wu Q; Zhuo ZJ; Zeng J; Zhang J; Zhu J; Zou Y; Zhang R; Yang T; Zhu D; He J; Xia H
    J Cancer; 2018; 9(3):535-539. PubMed ID: 29483959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor.
    Cimmino F; Avitabile M; Diskin SJ; Vaksman Z; Pignataro P; Formicola D; Cardinale A; Testori A; Koster J; de Torres C; Devoto M; Maris JM; Iolascon A; Capasso M
    Int J Cancer; 2018 Dec; 143(11):2828-2837. PubMed ID: 30132831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.
    Diskin SJ; Capasso M; Schnepp RW; Cole KA; Attiyeh EF; Hou C; Diamond M; Carpenter EL; Winter C; Lee H; Jagannathan J; Latorre V; Iolascon A; Hakonarson H; Devoto M; Maris JM
    Nat Genet; 2012 Oct; 44(10):1126-30. PubMed ID: 22941191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.
    Oldridge DA; Wood AC; Weichert-Leahey N; Crimmins I; Sussman R; Winter C; McDaniel LD; Diamond M; Hart LS; Zhu S; Durbin AD; Abraham BJ; Anders L; Tian L; Zhang S; Wei JS; Khan J; Bramlett K; Rahman N; Capasso M; Iolascon A; Gerhard DS; Guidry Auvil JM; Young RA; Hakonarson H; Diskin SJ; Look AT; Maris JM
    Nature; 2015 Dec; 528(7582):418-21. PubMed ID: 26560027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of
    Jia W; Zhu J; Fu W; Zhu S; Deng F; Xia H; Liu GC; He J
    J Oncol; 2019; 2019():3518149. PubMed ID: 31057612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
    Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM
    Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.
    Capasso M; Devoto M; Hou C; Asgharzadeh S; Glessner JT; Attiyeh EF; Mosse YP; Kim C; Diskin SJ; Cole KA; Bosse K; Diamond M; Laudenslager M; Winter C; Bradfield JP; Scott RH; Jagannathan J; Garris M; McConville C; London WB; Seeger RC; Grant SF; Li H; Rahman N; Rappaport E; Hakonarson H; Maris JM
    Nat Genet; 2009 Jun; 41(6):718-23. PubMed ID: 19412175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.
    Nguyen le B; Diskin SJ; Capasso M; Wang K; Diamond MA; Glessner J; Kim C; Attiyeh EF; Mosse YP; Cole K; Iolascon A; Devoto M; Hakonarson H; Li HK; Maris JM
    PLoS Genet; 2011 Mar; 7(3):e1002026. PubMed ID: 21436895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus.
    Russell MR; Penikis A; Oldridge DA; Alvarez-Dominguez JR; McDaniel L; Diamond M; Padovan O; Raman P; Li Y; Wei JS; Zhang S; Gnanchandran J; Seeger R; Asgharzadeh S; Khan J; Diskin SJ; Maris JM; Cole KA
    Cancer Res; 2015 Aug; 75(15):3155-66. PubMed ID: 26100672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidate Gene Association Analysis of Neuroblastoma in Chinese Children Strengthens the Role of LMO1.
    Lu J; Chu P; Wang H; Jin Y; Han S; Han W; Tai J; Guo Y; Ni X
    PLoS One; 2015; 10(6):e0127856. PubMed ID: 26030754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
    Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
    Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.
    Bosse KR; Diskin SJ; Cole KA; Wood AC; Schnepp RW; Norris G; Nguyen le B; Jagannathan J; Laquaglia M; Winter C; Diamond M; Hou C; Attiyeh EF; Mosse YP; Pineros V; Dizin E; Zhang Y; Asgharzadeh S; Seeger RC; Capasso M; Pawel BR; Devoto M; Hakonarson H; Rappaport EF; Irminger-Finger I; Maris JM
    Cancer Res; 2012 Apr; 72(8):2068-78. PubMed ID: 22350409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Colorectal cancer susceptibility genetic variants in tumor free and colorectal carcinoma bearing Hungarian population. Individual predisposition to cancer].
    Szentirmay Z; Kurcsics J; Csernák E; Tándor I; Tóth E
    Orv Hetil; 2018 Oct; 159(40):1614-1623. PubMed ID: 30277414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele-specific transcription factor binding to common and rare variants associated with disease and gene expression.
    Cavalli M; Pan G; Nord H; Wallerman O; Wallén Arzt E; Berggren O; Elvers I; Eloranta ML; Rönnblom L; Lindblad Toh K; Wadelius C
    Hum Genet; 2016 May; 135(5):485-497. PubMed ID: 26993500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population.
    He J; Zhong W; Zeng J; Zhu J; Zhang R; Wang F; Yang T; Zou Y; Xia H
    Oncotarget; 2016 Apr; 7(16):22770-8. PubMed ID: 27009839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population.
    Zhang R; Zou Y; Zhu J; Zeng X; Yang T; Wang F; He J; Xia H
    Int J Med Sci; 2016; 13(2):133-8. PubMed ID: 26941572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta-analysis of case-control studies.
    Hashemi M; Sarabandi S; Karami S; Śmieja J; Moazeni-Roodi A; Ghavami S; Łos MJ
    J Cell Mol Med; 2020 Jan; 24(2):1160-1168. PubMed ID: 31830377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.